Exploring the potential of gold(iii) cyclometallated compounds as cytotoxic agents: variations on the C^N theme

Keyphrases

• Cyclometalated Compounds 100%
• Cyclometallated 100%
• Cytotoxic Agents 100%
• Elemental Analysis 25%
• Phosphanes 25%
• Zinc Finger Protein 25%
• X-ray Diffraction Method 25%
• Colorectal Cancer 25%
• Mass Spectrometry Analysis 25%
• Phosphane Ligands 25%
• Healthy Individuals 25%
• In Vitro Screening 25%
• Human Cells 25%
• Potent Inhibitor 25%
• Colon Cancer Cells 25%
• PARP Inhibitor (PARPi) 25%
• Ovarian Cancer Cells 25%
• Breast Cancer Cells 25%
• Cancer Cell Lines 25%
• Toxicity Profile 25%
• Cisplatin Resistance 25%
• 2-Benzylpyridine 25%
• Far-IR 25%
• HCT116 Cells 25%
• Embryonic Kidney 25%
• Lung Cancer Cells 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Coenzyme Q - Cytochrome C Reductase 100%
• Cytotoxic Agent 100%
• Normal Human 50%
• Cisplatin 50%
• In Vitro Screening 50%
• Malignant Neoplasm 50%
• Lung Cancer 50%
• Colorectal Carcinoma 50%
• Protein P53 50%
• Ovary Cancer 50%
• Breast Cancer 50%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1 50%
• Elemental Analysis 50%
• Colon Carcinoma 50%
• Zinc Finger Protein 50%

Chemistry

• Phosphane 100%
• Cytotoxic Agent 100%
• Toxic 50%
• Elemental Analysis 50%
• Crystal Structure 50%
• Mass Spectrometry 50%
• X-Ray Diffraction 50%
• In Vitro Screening 50%
• Far-Infrared Spectroscopy 50%
• NMR Spectroscopy 50%
• Cisplatin 50%